Aristides Estrada
Internal Medicine · Mine Hill, NJNPI 1114970068
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 342 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,857 and has fallen 98.9% since, to $21 in 2024.
Across 342 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$564
- Amgen$427
- Lilly USA, LLC$342
- Merck$333
- Novartis$288
- plus $2K from 21 others
What the payments were for
- Consulting fees$1503%
- Food & beverage$4,66897%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 84 | $1,107 |
| AstraZeneca | 36 | $564 |
| Amgen | 32 | $427 |
| Lilly USA, LLC | 27 | $342 |
| Merck | 27 | $333 |
| Novartis | 20 | $288 |
| Amarin Pharma, Inc. | 19 | $267 |
| Boehringer Ingelheim | 18 | $256 |
| Bausch Health US, LLC | 12 | $176 |
| Pfizer | 11 | $174 |
| Bayer | 8 | $157 |
| Comsort, Inc | 1 | $150 |
| AbbVie(2 entities) | 15 | $144 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| Johnson & Johnson | 4 | $55 |
| Teva Pharmaceuticals USA, Inc. | 4 | $48 |
| Nalpropion Pharmaceuticals LLC | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Astellas Pharma US Inc | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Sanofi Pasteur Inc. | 2 | $25 |
| Exact Sciences | 1 | $24 |
| Abbott | 1 | $18 |
| Althera Pharmaceuticals LLC | 1 | $16 |
| Vivus LLC | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,824 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 24 | $147 |
| Atorvastatin Calcium | 20 | $89 |
| Losartan Potassium | 25 | $60 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Mine Hill
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.